PATENT CLAIM ANALYSIS

Application Number: 16176986
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "094500"]

Abstract:
The present invention provides engineered phenylalanine ammonia-lyase (PAL) polypeptides and compositions thereof, as well as polynucleotides encoding the engineered phenylalanine ammonia-lyase (PAL) polypeptides.

Claim (Index 27):
The pharmaceutical composition of  claim 21 , wherein said composition is coadministered with at least one additional therapeutically effective compound.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 97.0
- Lexical Diversity: 1.38095
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14255539', '15431491', '16176896', '16166359', '15720198']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.922650167907995
- 35 USC 102 Novelty (BERT): 0.7647427733482633
- Combined Prediction Score: 0.906859428452022
- Mean Citation Score: 1109.61082
- Max Citation Score: 1121.7992
- Similarity Product: 902.7768275214196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test